1999
DOI: 10.1016/s0014-5793(99)00741-3
|View full text |Cite
|
Sign up to set email alerts
|

Phosphorylation of tau protein by recombinant GSK‐3β: pronounced phosphorylation at select Ser/Thr‐Pro motifs but no phosphorylation at Ser262 in the repeat domain

Abstract: Glycogen synthase kinase-3L L (GSK-3L L) has been described as a proline-directed kinase which phosphorylates tau protein at several sites that are elevated in Alzheimer paired helical filaments. However, it has been claimed that GSK-3L L can also phosphorylate the non-proline-directed KXGS motifs in the presence of heparin, including Ser262 in the repeat domain of tau, which could induce the detachment of tau from microtubules. We have analyzed the activity of recombinant GSK-3L L and of GSK-3L L preparations… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
94
1

Year Published

2000
2000
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(103 citation statements)
references
References 60 publications
8
94
1
Order By: Relevance
“…This inhibition is not due to a direct effect of Dvl on GSK3b, as Dvl and GSK3b do not interact (Li et al 1999), and therefore other interacting proteins must be involved. Further, in the Mudher et al (2001) study tau phosphorylation at the 12E8 epitope (pSer262/356) was decreased by Dvl expression, despite the fact that the 12E8 epitope is not a GSK3b site (Godemann et al 1999). This suggests that Dvl may decrease tau phosphorylation by inhibiting the activity of some other protein kinase(s) and/or by increasing the activity of protein phosphatases, in concert with its effects on GSK3b mediated phosphorylation events.…”
Section: Discussionmentioning
confidence: 92%
“…This inhibition is not due to a direct effect of Dvl on GSK3b, as Dvl and GSK3b do not interact (Li et al 1999), and therefore other interacting proteins must be involved. Further, in the Mudher et al (2001) study tau phosphorylation at the 12E8 epitope (pSer262/356) was decreased by Dvl expression, despite the fact that the 12E8 epitope is not a GSK3b site (Godemann et al 1999). This suggests that Dvl may decrease tau phosphorylation by inhibiting the activity of some other protein kinase(s) and/or by increasing the activity of protein phosphatases, in concert with its effects on GSK3b mediated phosphorylation events.…”
Section: Discussionmentioning
confidence: 92%
“…This lead us to focus on GSK3␤, which is also of great interest in the context of AD because it phosphorylates Tau efficiently at Ser/Thr-Pro motifs that are elevated in AD (31,32). In addition, we could show that MARK and GSK3␤ copurified through several steps of purification (11,33).…”
Section: Gsk3␤ Phosphorylates Mark2 At Serine 212 and Reduces Itsmentioning
confidence: 90%
“…Total RNA was extracted from the cultures as described previously (Godemann et al, 1999). Total RNA was subjected to DnaseI treatment (Roche, Hertforshire, UK) and 2 g of total RNA/sample were used for cDNA synthesis using Superscript II (Invitrogen, San Diego, CA) and an oligodT primer.…”
Section: Methodsmentioning
confidence: 99%